These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 16151384)

  • 21. Efficacy of regulatory T-cell immunotherapy: are inflammatory cytokines key determinants?
    Bayry J; Lacroix-Desmazes S; Dasgupta S; Kazatchkine MD; Kaveri SV
    Nat Rev Immunol; 2008 Jan; 8(1):1p following 86; author reply 1p following 86. PubMed ID: 18049489
    [No Abstract]   [Full Text] [Related]  

  • 22. beta-Glycosphingolipids as immune modulators.
    Adar T; Ilan Y
    J Immunotoxicol; 2008 Apr; 5(2):209-20. PubMed ID: 18569392
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Engineering therapeutic monoclonal antibodies.
    Liu XY; Pop LM; Vitetta ES
    Immunol Rev; 2008 Apr; 222():9-27. PubMed ID: 18363992
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Demystifying the immune system and autoimmune disease.
    Ohio Nurses Foundation
    Ohio Nurses Rev; 2005; 80(6):18-22; quiz 23-4. PubMed ID: 16528893
    [No Abstract]   [Full Text] [Related]  

  • 25. B cell targeted therapy in autoimmunity.
    Blank M; Shoenfeld Y
    J Autoimmun; 2007; 28(2-3):62-8. PubMed ID: 17391915
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Monoclonal antibody successes in the clinic.
    Reichert JM; Rosensweig CJ; Faden LB; Dewitz MC
    Nat Biotechnol; 2005 Sep; 23(9):1073-8. PubMed ID: 16151394
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Anti-B-cell strategies in autoimmune diseases].
    Müller-Ladner U
    Z Rheumatol; 2009 Jul; 68(5):363. PubMed ID: 19513728
    [No Abstract]   [Full Text] [Related]  

  • 28. Kinoids: a family of immunogens for active anticytokine immunotherapy applied to autoimmune diseases and cancer.
    Bizzini B; Drouet B; Zagury D; Abitbol M; Burny A; Boissier MC
    Immunotherapy; 2010 May; 2(3):347-65. PubMed ID: 20635900
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Future perspectives of therapeutic monoclonal antibodies.
    Tsumoto K; Isozaki Y; Yagami H; Tomita M
    Immunotherapy; 2019 Feb; 11(2):119-127. PubMed ID: 30730271
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Advances in immunotherapy. Using the body's own immune system to fight cancer.
    Duke Med Health News; 2014 Aug; 20(8):6. PubMed ID: 25230429
    [No Abstract]   [Full Text] [Related]  

  • 31. [Immunology: new approaches to immuno-modulation and immunotherapy].
    Kabelitz D
    Dtsch Med Wochenschr; 2006 Jun; 131(25-26):1471-3. PubMed ID: 16794979
    [No Abstract]   [Full Text] [Related]  

  • 32. [Immunotherapy of malignant growth].
    Tobiasch V
    Lebensversicher Med; 1986 Sep; 38(5):133-9. PubMed ID: 2877376
    [No Abstract]   [Full Text] [Related]  

  • 33. [Monoclonal antibody therapy].
    Schäffner G; Kabelitz D
    Dtsch Med Wochenschr; 2001 Jul; 126(30):851-6. PubMed ID: 11512284
    [No Abstract]   [Full Text] [Related]  

  • 34. [Clinical applications of monoclonal antibodies].
    Boucheix C
    Rev Med Interne; 1985 Oct; 6(4):403-10. PubMed ID: 3906817
    [No Abstract]   [Full Text] [Related]  

  • 35. Antitumor activity in melanoma and anti-self responses in a phase I trial with the anti-cytotoxic T lymphocyte-associated antigen 4 monoclonal antibody CP-675,206.
    Ribas A; Camacho LH; Lopez-Berestein G; Pavlov D; Bulanhagui CA; Millham R; Comin-Anduix B; Reuben JM; Seja E; Parker CA; Sharma A; Glaspy JA; Gomez-Navarro J
    J Clin Oncol; 2005 Dec; 23(35):8968-77. PubMed ID: 16204013
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Immunotherapy: a 10-year anniversary issue.
    Gregg M
    Immunotherapy; 2019 Jan; 11(1):1-2. PubMed ID: 30702007
    [No Abstract]   [Full Text] [Related]  

  • 37. Update on therapeutic monoclonal antibodies.
    Bussel JB; Giulino L; Lee S; Patel VL; Sandborg C; Stiehm ER
    Curr Probl Pediatr Adolesc Health Care; 2007 Apr; 37(4):118-35. PubMed ID: 17434008
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cytokine, chemokine, and co-stimulatory fusion proteins for the immunotherapy of solid tumors.
    Khawli LA; Hu P; Epstein AL
    Handb Exp Pharmacol; 2008; (181):291-328. PubMed ID: 18071951
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Immunomodulation of autoimmune responses with monoclonal antibodies and immunoadhesins: treatment of ocular inflammatory disease in the next millennium.
    Dick AD; Isaacs JD
    Br J Ophthalmol; 1999 Nov; 83(11):1230-4. PubMed ID: 10535846
    [No Abstract]   [Full Text] [Related]  

  • 40. Opportunistic infections and other risks with newer multiple sclerosis therapies.
    Berger JR; Houff S
    Ann Neurol; 2009 Apr; 65(4):367-77. PubMed ID: 19399841
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.